Selank is a synthetic heptapeptide tuftsin analog. You get the Thr-Lys-Pro-Arg core extended with a Pro-Gly-Pro tail, which resists enzymatic cleavage and prolongs activity. This shifts an IgG Fc, derived immune pharmacophore toward central signaling. Researchers study how it modulates GABAergic neurotransmission, serotonin metabolism, and BDNF-linked neurotrophic pathways, driving anxiolytic, nootropic, and antistress effects. It’s often grouped within the glyproline family. The sections below cover how each mechanism and application unfolds.
Key Takeaways
- Selank is a synthetic heptapeptide (Thr-Lys-Pro-Arg-Pro-Gly-Pro) derived from tuftsin, an IgG Fc, derived immunomodulatory tetrapeptide (Thr-Lys-Pro-Arg).
- Its C-terminal Pro-Gly-Pro tail improves metabolic stability and prolongs activity by resisting rapid enzymatic degradation.
- Research links Selank to GABAergic modulation, showing anxiolytic and antistress effects comparable to diazepam in withdrawal models.
- Neuroactive studies examine serotonin metabolism and BDNF-related neurotrophic signaling supporting memory in hippocampus and frontal cortex.
- Selank shifts tuftsin’s immune profile toward central GABAergic, serotonergic, and neurotrophic modulation, differing from Semax’s melanocortin/BDNF-linked nootropic action.
What is Selank peptide and how is it structured
Selank is a synthetic heptapeptide tuftsin analog with the amino acid sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro (TKPRPGP). You’re looking at tuftsin’s endogenous tetrapeptide core (Thr-Lys-Pro-Arg), extended at the C-terminus with a Pro-Gly-Pro tail. That extension isn’t arbitrary. You add those three residues to improve metabolic stability and prolong activity, since the proline-rich tail resists rapid enzymatic cleavage that would otherwise degrade the parent fragment.
Tuftsin itself derives from the Fc region of IgG, giving Selank an immunologically active lineage. It is often classified within the glyproline or regulatory peptide family. By retaining tuftsin’s recognition motif while adding stability, Selank keeps its receptor-relevant pharmacophore intact and extends its functional window for research.
How is Selank related to tuftsin
Selank is a synthetic analog of tuftsin that preserves tuftsin’s core sequence and adds a Pro-Gly-Pro tail. Tuftsin is the endogenous tetrapeptide Thr-Lys-Pro-Arg, cleaved from the Fc region of IgG, and it carries immunomodulatory activity. Selank preserves this core sequence intact, then appends a Pro-Gly-Pro tail to form the heptapeptide TKPRPGP. That extension isn’t cosmetic. The added prolines and glycine resist enzymatic degradation, so you get prolonged metabolic stability and extended activity versus the parent peptide. Functionally, you inherit tuftsin’s regulatory-peptide roots while shifting the profile. Where tuftsin acts mainly on immune-cell signaling, Selank’s modified terminus redirects activity toward central nervous system targets, engaging GABAergic and serotonergic mechanisms. So you’re working with a stabilized analog that trades immune emphasis for neuroactive, anxiolytic function.
What neuroactive mechanisms does Selank research study
Selank research studies GABAergic neurotransmission, serotonin metabolism, and BDNF-related neurotrophic signaling as its main neuroactive mechanisms. Preclinical work links Selank to GABAergic modulation, positioning it alongside anxiolytic activity comparable to benzodiazepines like diazepam in withdrawal models. On the serotonergic side, one study showed Selank altered 5-HT metabolism in the rat brain stem within 30 minutes of injection, pointing to rapid central action. The third thread centers on neurotrophic signaling: Selank influences BDNF content in the hippocampus and frontal cortex, and it prevented ethanol-induced BDNF changes during alcohol withdrawal. Together, these mechanisms frame Selank as a neuroactive peptide acting through GABAergic tone, serotonin turnover, and neurotrophin-mediated plasticity, rather than the immune signaling its tuftsin parent typically drives.
Which research applications involve Selank
Selank is most often studied in anxiolytic, nootropic, addiction, ethanol-withdrawal, and immunomodulatory research applications. Anxiolytic studies lead, where GABAergic modulation drives the antistress and positive-emotional effects observed under conflict stress. Nootropic research follows, tracking cognitive-stimulating effects in aged rats at 0.3 mg/kg/day and BDNF-linked memory support in the hippocampus and frontal cortex. Addiction models show Selank cut the morphine withdrawal index by 39.6% and raised tactile sensitivity thresholds ninefold. Ethanol-withdrawal studies test whether it prevents BDNF disturbances and protects attention. Immunomodulatory work persists too, examining inflammation-related gene expression in spleen tissue, reflecting its tuftsin origins. Across these applications, the evidence is mostly animal and in vitro data, with limited independent clinical validation.
How does Selank compare to related neuropeptides
Selank differs from related neuropeptides by shifting tuftsin’s immune-signaling profile toward central GABAergic, serotonergic, and neurotrophic modulation. Tuftsin (Thr-Lys-Pro-Arg) drives immune-cell signaling, while Selank’s Pro-Gly-Pro extension shifts activity toward central GABAergic and serotonergic modulation. This is reflected in stability and target emphasis.
| Peptide | Primary Mechanistic Emphasis |
|---|---|
| Tuftsin | IgG Fc, derived immunomodulation |
| Selank | GABAergic, 5-HT, BDNF signaling |
| Semax | Melanocortin/BDNF-linked nootropic |
| Glyprolines | Regulatory stability, antistress |
Compared to Semax, another Russian-studied neuropeptide, Selank leans anxiolytic through GABA and serotonin pathways rather than melanocortin-driven cognition. The shared glyproline framework grants metabolic resistance, prolonging central action. So when you weigh Selank against relatives, you’re tracking a deliberate mechanistic pivot: from immune stimulation toward receptor-level neuromodulation and stress-resilient neurotrophic support. Selank in anxiolytic models illustrates its capacity to reduce anxiety through neurochemical pathways. Researchers have noted significant improvements in stress-related behaviors among subjects treated with Selank, reinforcing its potential as a therapeutic agent.
How to source and store research-grade Selank
Source research-grade Selank from suppliers who document peptide identity and purity with objective analytics. Demand HPLC purity data confirming ≥98% and mass spectrometry verifying the heptapeptide sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. These analytics confirm you’re handling the intended tuftsin analog, not a truncated fragment or degraded variant that could shift GABAergic or serotonergic activity in your assays.
Store lyophilized Selank at -20°C, protected from light and moisture, to preserve backbone integrity. After reconstituting it in sterile bacteriostatic water, aliquot immediately and refrigerate at 4°C for short-term work, or freeze aliquots at -20°C to limit freeze-thaw cycles that fragment the peptide.
Label each aliquot with concentration and date, since degradation directly compromises receptor-level reproducibility across your experimental replicates.
Order Research-Grade Peptides for Neuroactive Studies
Whether your research explores tuftsin analogs or broader neuroactive pathways, starting with verified peptides shapes reliable results. Every batch at Holas is backed by independent lab results for verified purity and batch consistency. Browse our full catalog or reach out to discuss your sourcing needs.
Frequently Asked Questions
Is Selank Approved for Clinical Use Outside of Russia?
No, Selank is not approved for clinical use outside Russia. The evidence base is dominated by animal studies and in vitro findings, with independent Western clinical validation remaining limited. It has been discussed in relation to Russian clinical research in anxiety, but public research summaries characterize it as a research peptide rather than a broadly established international medicine. Elsewhere it is strictly investigational.
What Routes of Administration Are Used in Selank Research?
Selank research relies mainly on injection routes, with intraperitoneal and intranasal delivery dominating the literature. In one 5-HT study, researchers injected Selank and measured brainstem serotonin metabolism within 30 minutes, confirming rapid CNS access. Intranasal administration takes advantage of the peptide’s stability, since the Pro-Gly-Pro residues resist enzymatic cleavage and prolong activity. Systemic regimens such as 0.3 mg/kg/day for 7 days have been used to target BDNF signaling in the hippocampus and frontal cortex.
Are There Documented Side Effects or Safety Concerns With Selank?
Documented toxicity is limited, since the safety data comes almost entirely from animal and in vitro work, and the evidence base is small with sparse independent Western validation. Because Selank modulates GABAergic and serotonergic signaling rather than strongly activating stimulatory receptors, researchers report a relatively benign profile in those models. Systematic long-term characterization has not been established in the available research summaries, so conclusions beyond that remain unsupported.
How Long Do Selank’s Effects Last After Administration?
Selank’s effects begin rapidly in research models; it altered 5-HT metabolism in rat brainstem within 30 minutes of injection. The Pro-Gly-Pro tail extends its metabolic stability compared with tuftsin, which points to a prolonged action window. The available research summaries do not pin down a precise duration, so while onset is fast, exact persistence after administration is not clearly quantified in the current evidence base.
Can Selank Be Combined With Other Research Peptides?
Direct combination data is not available, since studies isolate Selank to characterize its GABAergic and serotonergic actions. Mechanistically, it modulates 5-HT metabolism and BDNF signaling, so pairing it with peptides acting on overlapping neurotrophic or monoaminergic pathways could produce unpredictable receptor-level interactions. Additive effects cannot be assumed, and any co-administration remains an uncharacterized, purely experimental question.
